Literature DB >> 31902580

Discovery and Validation of Prediction Algorithms for Psychosis in Youths at Clinical High Risk.

Michelle A Worthington1, Hengyi Cao1, Tyrone D Cannon2.   

Abstract

In the past 2 to 3 decades, clinicians have used the clinical high risk for psychosis (CHR-P) paradigm to better understand factors that contribute to the onset of psychotic disorders. While this paradigm is useful to identify individuals at risk, the CHR-P criteria are not sufficient to predict outcomes from the CHR-P population. Because approximately 25% of the CHR-P population will ultimately convert to psychosis, more precise methods of prediction are needed to account for heterogeneity in both risk factors and outcomes in the CHR-P population. To this end, several groups in recent years have used data-driven approaches to refine predictive algorithms to predict both conversion to psychosis and functional outcomes. These models have generally used either clinical and behavioral data, including demographics and measures of symptom severity, neurocognitive functioning, and social functioning, or neuroimaging data, including structural and functional measures, to predict conversion to psychosis in CHR-P samples. This review focuses on the empirical models that have been derived within each of these lines of research and evaluates the performance and methodology of these models. This review also serves to inform best practices for data-driven approaches and directions moving forward to improve our prediction of psychotic disorders and associated outcomes. Because sample size is still the most critical consideration in the current models, we urge that algorithms to predict conversion be conducted using multisite data in order to obtain the power necessary to conclusively determine predictive accuracy without overfitting.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Clinical high risk; Machine learning; Neuroimaging; Predictive models; Psychosis; Risk prediction

Mesh:

Year:  2019        PMID: 31902580     DOI: 10.1016/j.bpsc.2019.10.006

Source DB:  PubMed          Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging        ISSN: 2451-9022


  5 in total

1.  Using Natural Language Processing on Electronic Health Records to Enhance Detection and Prediction of Psychosis Risk.

Authors:  Jessica Irving; Rashmi Patel; Dominic Oliver; Craig Colling; Megan Pritchard; Matthew Broadbent; Helen Baldwin; Daniel Stahl; Robert Stewart; Paolo Fusar-Poli
Journal:  Schizophr Bull       Date:  2021-03-16       Impact factor: 9.306

2.  Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis.

Authors:  Michelle A Worthington; Jean Addington; Carrie E Bearden; Kristin S Cadenhead; Barbara A Cornblatt; Matcheri Keshavan; Daniel H Mathalon; Thomas H McGlashan; Diana O Perkins; William S Stone; Ming T Tsuang; Elaine F Walker; Scott W Woods; Tyrone D Cannon
Journal:  Schizophr Bull       Date:  2022-03-01       Impact factor: 7.348

3.  Real-world implementation of precision psychiatry: Transdiagnostic risk calculator for the automatic detection of individuals at-risk of psychosis.

Authors:  Dominic Oliver; Giulia Spada; Craig Colling; Matthew Broadbent; Helen Baldwin; Rashmi Patel; Robert Stewart; Daniel Stahl; Richard Dobson; Philip McGuire; Paolo Fusar-Poli
Journal:  Schizophr Res       Date:  2020-06-19       Impact factor: 4.939

4.  Brain connectomes in youth at risk for serious mental illness: an exploratory analysis.

Authors:  Paul D Metzak; Mohammed K Shakeel; Xiangyu Long; Mike Lasby; Roberto Souza; Signe Bray; Benjamin I Goldstein; Glenda MacQueen; JianLi Wang; Sidney H Kennedy; Jean Addington; Catherine Lebel
Journal:  BMC Psychiatry       Date:  2022-09-15       Impact factor: 4.144

Review 5.  Selective Review of Neuroimaging Findings in Youth at Clinical High Risk for Psychosis: On the Path to Biomarkers for Conversion.

Authors:  Justin K Ellis; Elaine F Walker; David R Goldsmith
Journal:  Front Psychiatry       Date:  2020-09-23       Impact factor: 4.157

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.